Company / Net Income
IDEAYA Biosciences, Inc. Net Income History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$113.7M
FY2025
5-year range
-$274.5M / -$34.5M
FY2021-FY2025
Trend
+58.6%
vs FY2024
Sector context
#115 of 216
Health Care
What the data says
At -$114M, IDEAYA Biosciences, Inc.'s net income ranks #115 of 216 in the Health Care sector. Net Income returned to growth in FY2025 after 2 years of decline, reaching -$114M.
Based on SEC 10-K filings.
-$114M in FY2025.
Remained stable around -$114M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#115 of 216 in Health CareTop 53% of 216This company -$113.7M Sector average $454.1M
▼
-125.0% below sector average
Key checks
Key Insights
- In FY2025, net income increased 58.6% year-over-year.
- Ranks #115 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2017.
- Lowest net income in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 4.55 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$113.7M | +58.6% |
| FY2024 | -$274.5M | -143.0% |
| FY2023 | -$113.0M | -227.5% |
| FY2022 | -$34.5M | +17.8% |
| FY2021 | -$42.0M | -22.2% |
| FY2020 | -$34.3M | +18.2% |
| FY2019 | -$42.0M | -22.2% |
| FY2018 | -$34.3M | -189.5% |
| FY2017 | -$11.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026